Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
Closed Posted
- Opportunity number
- PAR-22-114
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.393 Cancer Cause and Prevention Research
- 93.394 Cancer Detection and Diagnosis Research
- 93.395 Cancer Treatment Research
- 93.396 Cancer Biology Research
- 93.397 Cancer Centers Support Grants
- 93.398 Cancer Research Manpower
- 93.399 Cancer Control
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- Non-501(c)(3) Nonprofits
- Small Businesses
- State Governments
- Higher Education Inst. (Public)
- Tribal Governments (Federally Recognized)
- Special District Governments
- Independent School Districts
- Other
- 501(c)(3) Nonprofits
- Public or Indian Housing Auth.
- Tribal Organizations (Not Federally Recognized)
- For Profit Organizations
- County Governments
- City/Township Governments
- Higher Education Inst. (Private)
- Full announcement
Opportunity details come from Grants.gov. Updated .
Synopsis
The purpose of this trans-NCI Funding Opportunity Announcement (FOA) is to promote new cancer disparities research among investigators who do not normally conduct it and to encourage the partnership of experienced cancer research investigators with cancer disparities-focused researchers. This FOA is intended to accelerate and strengthen multi-disciplinary cancer disparities research in wide ranging areas. Cancer disparities research includes, but is not limited to basic, translational, behavioral, observational, interventional, environmental and population research studies that address the adverse differences in cancer incidence, prevalence, mortality, survivorship, burden and/or response to treatment in racial/ethnic minorities and/or underserved population groups. Proposed collaborations should focus on achieving research objectives that by necessity rely on diverse and complementary expertise, technical capabilities, and resource sets. Importantly, the supplemental request is required to be within the scope of the parent award and should expand the original aims to include a cancer disparity component and possible inclusion of international comparator cohorts. A trans NCI effort, the concept reissuance of the Collaborative Program is supported by NCIs Division of Cancer Biology (DCB), Division of Cancer Treatment and Diagnosis (DCTD), Division of Cancer Prevention (DCP), Division of Cancer Control and Population Sciences (DCCPS), Center to Reduce Cancer Health Disparities (CRCHD) and now, also included Center for Global Health.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity